SC 13G

Company

BIOCRYST PHARMACEUTICALS INC

Filed

June 10, 2020

Accession Number

0001104659-20-072065

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →